Ray Dalio's TMO Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 1,686 shares of Thermo Fisher Scientific Inc. (TMO) worth $976,953, representing 0.00% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 89,233 shares. Largest reduction occurred in Q2 2022, reducing 74,057 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2014 | +42,130 | New Buy | 42,130 | $120.25 |
| Q2 2014 | -42,130 | Sold Out | 0 | $0.00 |
| Q4 2014 | +11,899 | New Buy | 11,899 | $125.30 |
| Q1 2015 | -11,899 | Sold Out | 0 | $0.00 |
| Q2 2015 | +43,723 | New Buy | 43,723 | $129.75 |
| Q3 2015 | -13,219 | Reduce 30.23% | 30,504 | $122.28 |
| Q4 2015 | -30,504 | Sold Out | 0 | $0.00 |
| Q2 2016 | +12,466 | New Buy | 12,466 | $147.76 |
| Q3 2016 | -1,866 | Reduce 14.97% | 10,600 | $159.06 |
| Q4 2016 | +18,100 | Add 170.75% | 28,700 | $141.11 |
| Q1 2017 | -19,856 | Reduce 69.18% | 8,844 | $153.55 |
| Q2 2017 | +1,350 | Add 15.26% | 10,194 | $174.51 |
| Q3 2017 | -10,194 | Sold Out | 0 | $0.00 |
| Q2 2018 | +19,692 | New Buy | 19,692 | $207.14 |
| Q3 2018 | -13,274 | Reduce 67.41% | 6,418 | $244.16 |
| Q4 2018 | -6,418 | Sold Out | 0 | $0.00 |
| Q1 2020 | +12,913 | New Buy | 12,913 | $283.59 |
| Q2 2020 | -12,913 | Sold Out | 0 | $0.00 |
| Q3 2021 | +8,779 | New Buy | 8,779 | $571.36 |
| Q4 2021 | +37,737 | Add 429.86% | 46,516 | $667.23 |
| Q1 2022 | +89,233 | Add 191.83% | 135,749 | $590.65 |
| Q2 2022 | -74,057 | Reduce 54.55% | 61,692 | $543.28 |
| Q3 2022 | +79,441 | Add 128.77% | 141,133 | $507.19 |
| Q4 2022 | -38,541 | Reduce 27.31% | 102,592 | $550.69 |
| Q1 2023 | -6,975 | Reduce 6.80% | 95,617 | $576.37 |
| Q2 2023 | -11,970 | Reduce 12.52% | 83,647 | $521.75 |
| Q3 2023 | -41,562 | Reduce 49.69% | 42,085 | $506.17 |
| Q4 2023 | -42,085 | Sold Out | 0 | $0.00 |
| Q2 2024 | +33,729 | New Buy | 33,729 | $553.00 |
| Q3 2024 | -33,729 | Sold Out | 0 | $0.00 |
| Q4 2025 | +1,686 | New Buy | 1,686 | $579.45 |
Ray Dalio's Thermo Fisher Scientific Investment FAQs
Ray Dalio first purchased Thermo Fisher Scientific Inc. (TMO) in Q1 2014, acquiring 42,130 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Thermo Fisher Scientific Inc. (TMO) for 31 quarters since Q1 2014.
Ray Dalio's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q1 2022, adding 135,749 shares worth $80.18 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 1,686 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $976,953.
As of the Q4 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Thermo Fisher Scientific Inc. (TMO) was 141,133 shares, as reported at the end of Q3 2022.